F
Fitpet
Improving the quality of life of companion animals and human caregivers through technological advancements
About Fitpet
Fitpet was founded in 2017 by Junguk Ko, a former Samsung SDS engineer, who was inspired to start the company after his pet dog fell ill. The company focuses on providing diagnostic kits and apps for disease detection in pets, aiming to improve the quality of life for both pets and their owners.
In its journey, Fitpet has successfully raised significant funding to expand its operations. The company closed a Series B funding round with a cumulative amount of $26 million, marking it as the largest funding round among pet startups in Korea. This financial boost has allowed Fitpet to enhance its technological offerings and expand its market presence.
Fitpet's innovative approach to pet healthcare has attracted attention not only from pet owners but also from investors, leading to a total funding of $4.58 million over three rounds from six investors, including notable names like LB Investment and Samsung Venture Investment.
With a strong foundation and a clear vision, Fitpet continues to lead in the pet healthcare industry, leveraging technology to provide better health solutions for pets. The company's journey reflects a commitment to innovation and a passion for improving pet care, setting a new standard in the industry.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Seoul, South Korea
- Employees
- 71
- Open positions
- None listed
- Dealroom signal
- 65.2/100
- Industry
- Health, Home Living
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Veterinary, Hard Tech
- Technology
- Mobile app
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jun 2023 | $22M | $130M | Undisclosed | ↗ |
| LATE VCOther financing | Mar 2023 | $3.8M | $130M | Dongwha Pharm | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Fitpet is 5K monthly website visits, up 11.1% over the last three months. Fitpet's team declined 4.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
LB Investment
Mirae Asset Capital
PNP Investment
Premier Partners- LILSK Investment
Series B and later1 investor entered at this stage
- DPDongwha Pharm
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Fitpet on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Fitpet’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.